Detalles de la búsqueda
1.
Purmorphamine, a Smo-Shh/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis.
Neurochem Res
; 49(6): 1556-1576, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160216
2.
The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders.
Biogerontology
; 24(4): 493-531, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097427
3.
Correction to: The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders.
Biogerontology
; 24(5): 829, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486569
4.
Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions.
Neurotox Res
; 40(2): 670-686, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156173
5.
Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions.
Mol Neurobiol
; 59(6): 3888-3912, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437700
6.
Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats.
Toxicol Rep
; 9: 977-998, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783250
7.
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis.
Genes (Basel)
; 13(8)2022 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35893061
8.
Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.
Brain Sci
; 12(3)2022 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326298
9.
Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder.
Pharmaceuticals (Basel)
; 15(8)2022 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36015107
Resultados
1 -
9
de 9
1
Próxima >
>>